Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
Signaling by NOTCH1	4/73	4.76908113176592E-6	0.0016126071422613195	0	0	42.72678475577026	523.5465430783922	TLE4;HDAC5;EP300;ARRB1
Pathways in cancer	6/325	9.188644685249684E-6	0.0016126071422613195	0	0	14.783699059561128	171.4545723788314	MAX;CDH1;PRKCB;ZBTB16;EP300;STK4
Wnt signaling pathway	5/231	2.6173006661621553E-5	0.0029051483922551144	0	0	16.799693669162696	177.2499048711033	TLE4;PRKCB;PRKCD;EP300;ARRB1
Signaling by NOTCH	4/119	3.310710418524347E-5	0.0029051483922551144	0	0	25.576811594202898	263.8443182779199	TLE4;HDAC5;EP300;ARRB1
Regulation of transcription by NOTCH1 intracellular domain	3/47	5.220207166061507E-5	0.003353777579276121	0	0	48.51866883116883	478.41291820446094	TLE4;HDAC5;EP300
Kit receptor signaling pathway	3/54	7.926921176078046E-5	0.003353777579276121	0	0	41.84453781512605	395.1237750334599	PRKCB;EP300;JAK2
Calcineurin-dependent NFAT signaling role in lymphocytes	3/55	8.375456648902339E-5	0.003353777579276121	0	0	41.03777472527472	385.2470291649699	PRKCB;PRKCD;EP300
TAp63 pathway	3/55	8.375456648902339E-5	0.003353777579276121	0	0	41.03777472527472	385.2470291649699	VDR;PRKCD;EP300
Integrated breast cancer pathway	4/152	8.599429690451592E-5	0.003353777579276121	0	0	19.84084084084084	185.73466615098422	MAX;CDH1;ZMYND8;EP300
MAPK signaling pathway	5/314	1.1227511473501738E-4	0.0035575751093703746	0	0	12.235499128703012	111.27646036457539	MAX;PRKCB;PRKCD;ARRB1;STK4
Attenuation of GPCR signaling	2/11	1.2676847134630674E-4	0.0035575751093703746	0	0	152.95019157088123	1372.4447355060008	PRKCB;ARRB1
Angiotensin II-stimulated signaling through G-proteins and beta-arrestin	3/64	1.3176204108779165E-4	0.0035575751093703746	0	0	34.967213114754095	312.4150194923675	PRKCB;PRKCD;ARRB1
Endothelins	3/64	1.3176204108779165E-4	0.0035575751093703746	0	0	34.967213114754095	312.4150194923675	PRKCB;PRKCD;JAK2
Signaling events mediated by HDAC class I	3/70	1.720293598699515E-4	0.00431302180816807	0	0	31.826226012793178	275.86480670614424	HDAC5;MAX;EP300
Chemokine signaling pathway	4/189	1.9906522321036066E-4	0.004658126223122439	0	0	15.843043043043043	135.01248047034073	PRKCB;PRKCD;ARRB1;JAK2
Nuclear beta-catenin signaling and target gene transcription regulation	3/80	2.555091925827865E-4	0.005605232912284879	0	0	27.679035250463823	228.9679594188651	TLE4;CDH1;EP300
SMAD2/3 nuclear pathway	3/82	2.748359360217822E-4	0.005674553737861503	0	0	26.975587703435806	221.18191370685673	MAX;VDR;EP300
Interferon-gamma signaling pathway	3/97	4.5042912506562216E-4	0.008574870543528023	0	0	22.65387537993921	174.55512838852647	PRKCD;EP300;JAK2
Wnt signaling pathway and pluripotency	3/98	4.64166781558497E-4	0.008574870543528023	0	0	22.414285714285715	172.03561911780767	PRKCB;PRKCD;EP300
TPO signaling pathway	2/25	6.82184965402003E-4	0.011650534874821993	0	0	59.80809595202399	436.0135628403547	PRKCB;JAK2
Hemostasis pathway	5/468	7.057848150586512E-4	0.011650534874821993	0	0	8.101844160159494	58.78860290311209	PRKCB;PRKCD;EP300;ARRB1;JAK2
CARM1 and regulation of the estrogen receptor	2/26	7.383210151112932E-4	0.011650534874821993	0	0	57.3132183908046	413.29317445587276	HDAC5;EP300
RORA activates circadian expression	2/27	7.966177692185978E-4	0.011650534874821993	0	0	55.01793103448276	392.5603973248657	CHD9;EP300
Control of gene expression by vitamin D receptor	2/27	7.966177692185978E-4	0.011650534874821993	0	0	55.01793103448276	392.5603973248657	VDR;EP300
Retinoic acid receptor-mediated signaling	2/30	9.844083630700538E-4	0.013289512901445727	0	0	49.11576354679803	340.05150286391984	VDR;EP300
MicroRNAs in muscle cell differentiation	2/30	9.844083630700538E-4	0.013289512901445727	0	0	49.11576354679803	340.05150286391984	PRKCB;PRKCD
EGF/EGFR signaling pathway	3/141	0.0013341986642578978	0.016798013046574425	0	0	15.396739130434783	101.91755097058919	PRKCB;PRKCD;JAK2
MEF2D role in T cell apoptosis	2/35	0.0013400124367637719	0.016798013046574425	0	0	41.66353187042842	275.6074457457441	PRKCB;EP300
Calcium regulation in the cardiac cell	3/149	0.0015631127140293436	0.01847042544878725	0	0	14.547211350293543	93.99063981328503	PRKCB;PRKCD;ARRB1
BMAL1-CLOCK/NPAS2 activates circadian expression	2/38	0.001578668841776688	0.01847042544878725	0	0	38.18582375478927	246.34336634964797	CHD9;EP300
PAC1 receptor pathway	2/40	0.0017482077236044978	0.019195587777819864	0	0	36.172413793103445	229.6645937348641	PRKCB;PRKCD
Myometrial relaxation and contraction pathways	3/155	0.001750025096553378	0.019195587777819864	0	0	13.96875	88.67537319272091	PRKCB;PRKCD;ARRB1
Bioactive peptide-induced signaling pathway	2/41	0.0018360888409485233	0.01952930858099793	0	0	35.243147656940764	222.03597482014473	PRKCB;JAK2
Growth hormone receptor signaling	2/43	0.00201804338139322	0.02023809219625772	0	0	33.5206055508831	208.01637017204203	PRKCB;JAK2
PI3K class IB pathway in neutrophils	2/43	0.00201804338139322	0.02023809219625772	0	0	33.5206055508831	208.01637017204203	PRKCB;PRKCD
G alpha (z) signaling events	2/45	0.002208213087720262	0.021530077605272556	0	0	31.958299919807537	195.44327291118304	PRKCB;PRKCD
Fatty acid, triacylglycerol, and ketone body metabolism	3/173	0.002392768780111546	0.022578869550603432	0	0	12.478361344537815	75.31070536104531	PRKAB2;CHD9;EP300
HES/HEY pathway	2/48	0.0025087632834003815	0.022578869550603432	0	0	29.869565217391305	178.85792193078825	EP300;JAK2
Energy metabolism	2/48	0.0025087632834003815	0.022578869550603432	0	0	29.869565217391305	178.85792193078825	PRKAB2;EP300
Type II interferon signaling (interferon-gamma)	2/50	0.0027192556482504363	0.02386146831339758	0	0	28.62212643678161	169.08226656127547	PRKCD;JAK2
Apoptotic execution  phase	2/52	0.002937791521612053	0.024897006179513154	0	0	27.474482758620688	160.1789039869191	CDH1;PRKCD
Thrombin signaling through protease-activated receptors	2/53	0.003050060586094204	0.024897006179513154	0	0	26.934415145368494	156.02012683130314	PRKCB;ARRB1
PI3K pathway	2/53	0.003050060586094204	0.024897006179513154	0	0	26.934415145368494	156.02012683130314	PRKCB;PRKCD
Non-small cell lung cancer	2/54	0.0031643223277353994	0.025242662205343755	0	0	26.415119363395224	152.0405762035586	PRKCB;STK4
Thromboxane A2 receptor signaling	2/56	0.003398799697079565	0.026280216010409585	0	0	25.434227330779056	144.5766162187934	PRKCB;PRKCD
Keratinocyte differentiation	2/57	0.003519003283445158	0.026280216010409585	0	0	24.9705329153605	141.07296061152428	PRKCB;PRKCD
Mechanism of gene regulation by peroxisome proliferators via PPAR-alpha	2/57	0.003519003283445158	0.026280216010409585	0	0	24.9705329153605	141.07296061152428	PRKCB;EP300
Immune system	6/998	0.0038286771069094574	0.02765722370900625	0	0	4.5912096774193545	25.551165097277277	CDH1;PRKCB;ZBTB16;PRKCD;EP300;JAK2
Platelet activation, signaling and aggregation	3/205	0.0038609799479809295	0.02765722370900625	0	0	10.484618104667609	58.26128503661959	PRKCB;PRKCD;ARRB1
Circadian rhythm	2/62	0.004149430576332218	0.028806013470469672	0	0	22.883908045977012	125.51329647647898	CHD9;EP300
Antigen-activated B-cell receptor generation of second messengers	3/211	0.0041854891367349096	0.028806013470469672	0	0	10.179086538461538	55.7420185041041	MAX;PRKCB;PRKCD
G alpha 13 pathway	2/67	0.004828328046458851	0.03196377630930061	0	0	21.118302387267903	112.62929246148852	PRKCB;PRKCD
Adipocytokine signaling pathway	2/67	0.004828328046458851	0.03196377630930061	0	0	21.118302387267903	112.62929246148852	PRKAB2;JAK2
Cell cycle	4/453	0.0050348304772640734	0.03196377630930061	0	0	6.440650004124391	34.07989713509662	HDAC5;MAX;CDH1;EP300
G alpha q pathway	2/70	0.005258625119570298	0.03196377630930061	0	0	20.183569979716026	105.921067676316	PRKCB;PRKCD
Signaling events mediated by VEGFR1 and VEGFR2	2/70	0.005258625119570298	0.03196377630930061	0	0	20.183569979716026	105.921067676316	PRKCB;PRKCD
Long-term potentiation	2/70	0.005258625119570298	0.03196377630930061	0	0	20.183569979716026	105.921067676316	PRKCB;EP300
Interleukin-6 signaling pathway	2/71	0.0054058487402184816	0.03196377630930061	0	0	19.89005497251374	103.83153308233095	PRKCD;JAK2
Mitochondrial pathway of apoptosis: multidomain Bcl-2 family	2/71	0.0054058487402184816	0.03196377630930061	0	0	19.89005497251374	103.83153308233095	PRKCB;PRKCD
Leishmaniasis	2/72	0.0055549582759753195	0.03196377630930061	0	0	19.604926108374386	101.8096431909553	PRKCB;JAK2
Myocyte adrenergic pathway	2/72	0.0055549582759753195	0.03196377630930061	0	0	19.604926108374386	101.8096431909553	ZMYND8;ARRB1
Myc repressed pathway	2/73	0.005705947915146924	0.03213192128842668	0	0	19.327829043224867	99.85232246586659	MAX;EP300
Adherens junction cell adhesion	2/74	0.0058588118588584264	0.03213192128842668	0	0	19.058429118773947	97.95667503624674	CDH1;EP300
Wnt/calcium/cyclic GMP pathway	2/74	0.0058588118588584264	0.03213192128842668	0	0	19.058429118773947	97.95667503624674	PRKCB;PRKCD
Transcriptional regulation of white adipocyte differentiation	2/77	0.006328591715250412	0.034174395262352227	0	0	18.293333333333333	92.61324789757649	CHD9;EP300
Fc epsilon receptor I signaling pathway	2/79	0.006651044056183717	0.035371461571522496	0	0	17.81639050604568	89.31323485812854	PRKCB;PRKCD
T cell signal transduction	2/83	0.007317980393162851	0.03715163966372102	0	0	16.933163048105577	83.26748973447718	PRKCB;PRKCD
MicroRNAs in cardiomyocyte hypertrophy	2/85	0.007662373287066687	0.03715163966372102	0	0	16.523473203157458	80.49300113975073	HDAC5;PRKCB
Myc active pathway	2/85	0.007662373287066687	0.03715163966372102	0	0	16.523473203157458	80.49300113975073	MAX;EP300
AMPK inhibition of chREBP transcriptional activation activity	1/5	0.007726694289035996	0.03715163966372102	0	0	166.375	809.0939625056958	PRKAB2
Phospholipase C delta-1 interactions in phospholipid-associated cell signaling	1/5	0.007726694289035996	0.03715163966372102	0	0	166.375	809.0939625056958	PRKCB
Ion channel and phorbal esters signaling pathway	1/5	0.007726694289035996	0.03715163966372102	0	0	166.375	809.0939625056958	PRKCB
Disinhibition of SNARE formation	1/5	0.007726694289035996	0.03715163966372102	0	0	166.375	809.0939625056958	PRKCB
Neural crest differentiation	2/91	0.008738708384625295	0.041449819500047	0	0	15.404881828748547	73.0190302211722	HDAC5;CDH1
Insulin signaling pathway	3/277	0.008870468539664972	0.041513792765632065	0	0	7.701381647549531	36.389241313318074	PRKAB2;PRKCB;PRKCD
Interleukin-2 signaling pathway	5/847	0.009154551492849446	0.042279573341975726	0	0	4.368490772885072	20.503529320409587	PRKCB;ZBTB16;PRKCD;TLK1;JAK2
Fc gamma receptor-mediated phagocytosis	2/94	0.00930087394698537	0.042397490329764476	0	0	14.900299850074962	69.69834155839186	PRKCB;PRKCD
G-protein signaling pathways	2/95	0.009491780601043434	0.04271301270469545	0	0	14.739340007415647	68.64595646463037	PRKCB;PRKCD
Mitochondrial pathway of apoptosis: BH3-only Bcl-2 family	2/97	0.009878837910766144	0.043892051983277426	0	0	14.427586206896551	66.61736514007372	PRKCB;PRKCD
GnRH signaling pathway	2/101	0.010673774444413626	0.045133513728751386	0	0	13.841866945315221	62.841598838595445	PRKCB;PRKCD
Melanogenesis	2/101	0.010673774444413626	0.045133513728751386	0	0	13.841866945315221	62.841598838595445	PRKCB;EP300
Gamma-secretase-mediated ErbB4 signaling pathway	1/7	0.010801182772692638	0.045133513728751386	0	0	110.90555555555555	502.1914056148727	PRKCB
Activation of PKC through G-protein coupled receptors	1/7	0.010801182772692638	0.045133513728751386	0	0	110.90555555555555	502.1914056148727	PRKCB
PELP1 modulation of estrogen receptor activity	1/7	0.010801182772692638	0.045133513728751386	0	0	110.90555555555555	502.1914056148727	EP300
Interleukin-4 signaling pathway	2/104	0.011288023602032479	0.04661289746251059	0	0	13.432724814063556	60.232512336226115	EP300;JAK2
Fibroblast growth factor receptor pathway	2/105	0.011496181765014754	0.046920462785118355	0	0	13.301640441914964	59.401672032660606	PRKCB;PRKCD
G alpha i pathway	2/108	0.01213080582261541	0.048106379267353505	0	0	12.923227065712426	57.017369905230545	PRKCB;PRKCD
Import of palmitoyl-CoA into the mitochondrial matrix	1/8	0.012334969042911155	0.048106379267353505	0	0	95.05714285714286	417.8062796500496	PRKAB2
Stabilization of mRNA by HuR	1/8	0.012334969042911155	0.048106379267353505	0	0	95.05714285714286	417.8062796500496	PRKCD
Vitamin D biosynthesis	1/8	0.012334969042911155	0.048106379267353505	0	0	95.05714285714286	417.8062796500496	VDR
Epidermal growth factor receptor (EGFR) pathway	2/111	0.012780541205787276	0.04929637322232235	0	0	12.565643783612781	54.784089372696045	PRKCB;PRKCD
Lipid metabolism regulation by peroxisome proliferator-activated receptor alpha (PPAR-alpha)	2/112	0.013000452731669755	0.049599553356696566	0	0	12.450783699059562	54.070903578467814	CHD9;EP300
Gene expression regulation by hypoxia-inducible factor	1/9	0.013866454289070039	0.05080952458363235	0	0	83.17083333333333	355.82833874131705	EP300
PPAR-gamma coactivator role in obesity and thermogenesis	1/9	0.013866454289070039	0.05080952458363235	0	0	83.17083333333333	355.82833874131705	EP300
CXCR4 signaling pathway	2/116	0.013896622108343892	0.05080952458363235	0	0	12.011494252873563	51.362464469699084	PRKCB;JAK2
Vascular smooth muscle contraction	2/116	0.013896622108343892	0.05080952458363235	0	0	12.011494252873563	51.362464469699084	PRKCB;PRKCD
p53 activity regulation	2/118	0.014354546590391716	0.0519427407549226	0	0	11.80321046373365	50.08914911460411	PRKCD;EP300
Notch signaling pathway	2/121	0.015053614496342767	0.053503665934001784	0	0	11.503911909591423	48.271992142820785	EP300;JAK2
Phospholipase C signaling pathway	1/10	0.015395641764484845	0.053503665934001784	0	0	73.92592592592592	308.5424792813036	PRKCB
Activation of Src by protein tyrosine phosphatase alpha	1/10	0.015395641764484845	0.053503665934001784	0	0	73.92592592592592	308.5424792813036	PRKCB
Rheb GTPase activity by AMPK regulation	1/10	0.015395641764484845	0.053503665934001784	0	0	73.92592592592592	308.5424792813036	PRKAB2
Factors involved in megakaryocyte development and platelet production	2/125	0.016008223510813182	0.05508712208132772	0	0	11.127558172133446	46.00858865617668	EP300;JAK2
Apoptotic cleavage of cell adhesion  proteins	1/11	0.016922534733464	0.05521185523201113	0	0	66.53	271.3831303578043	CDH1
Reversal of insulin resistance by leptin	1/11	0.016922534733464	0.05521185523201113	0	0	66.53	271.3831303578043	PRKAB2
SUMOylation as a mechanism to modulate CtBP-dependent gene responses	1/11	0.016922534733464	0.05521185523201113	0	0	66.53	271.3831303578043	CDH1
Telomerase protein component gene hTERT transcriptional regulation	1/11	0.016922534733464	0.05521185523201113	0	0	66.53	271.3831303578043	MAX
Erythropoietin-mediated neuroprotection through NF-kB	1/11	0.016922534733464	0.05521185523201113	0	0	66.53	271.3831303578043	JAK2
PDGFB signaling pathway	2/129	0.016988263148311117	0.05521185523201113	0	0	10.774911756720066	43.9102713988681	PRKCD;JAK2
Tight junction	2/133	0.017993403660212643	0.057942061327840716	0	0	10.443801000263226	41.96058200741095	PRKCB;PRKCD
Beta-arrestins in GPCR desensitization	1/12	0.018447136470887412	0.05886313546619529	0	0	60.47878787878788	241.48249384895686	ARRB1
Adrenergic pathway	2/137	0.01902331815568447	0.06015481687067792	0	0	10.132311621966794	40.14512833475264	PRKCB;PRKCD
Signal transduction	5/1020	0.019237416576718826	0.06028868945025275	0	0	3.5911330049261085	14.188200624614955	HDAC5;CDH1;EP300;ARRB1;JAK2
p53 signaling pathway	2/139	0.019547464278656834	0.06042480208244607	0	0	9.983387868109741	39.28372981479435	VDR;EP300
CBL-mediated ligand-induced downregulation of EGF receptors	1/13	0.019969450260865367	0.06042480208244607	0	0	55.43611111111111	216.95208467294643	PRKCB
Interleukin-22 soluble receptor signaling pathway	1/13	0.019969450260865367	0.06042480208244607	0	0	55.43611111111111	216.95208467294643	JAK2
Melanocyte development and pigmentation pathway	1/13	0.019969450260865367	0.06042480208244607	0	0	55.43611111111111	216.95208467294643	EP300
Interferon gamma signaling regulation	1/14	0.02148947938555657	0.06132363629536875	0	0	51.16923076923077	196.4996601316088	JAK2
CARM1 transcriptional regulation by protein methylation	1/14	0.02148947938555657	0.06132363629536875	0	0	51.16923076923077	196.4996601316088	EP300
MAP kinase inactivation of SMRT corepressor	1/14	0.02148947938555657	0.06132363629536875	0	0	51.16923076923077	196.4996601316088	ZBTB16
T cell receptor/JNK pathway	1/14	0.02148947938555657	0.06132363629536875	0	0	51.16923076923077	196.4996601316088	PRKCB
T cell receptor/Ras pathway	1/14	0.02148947938555657	0.06132363629536875	0	0	51.16923076923077	196.4996601316088	PRKCB
TRAF3-dependent IRF activation pathway	1/14	0.02148947938555657	0.06132363629536875	0	0	51.16923076923077	196.4996601316088	EP300
Visual signal transduction	1/14	0.02148947938555657	0.06132363629536875	0	0	51.16923076923077	196.4996601316088	ARRB1
Prolactin receptor signaling pathway	1/15	0.023007227131928758	0.06460429378645595	0	0	47.51190476190476	179.21238137059572	JAK2
TrkA receptor signaling pathway	1/15	0.023007227131928758	0.06460429378645595	0	0	47.51190476190476	179.21238137059572	PRKCB
Acetylation and deacetylation of RelA in the nucleus	1/16	0.024522696784534302	0.06672454706489565	0	0	44.34222222222222	164.42788585185278	EP300
GluR2-containing AMPA receptor trafficking	1/16	0.024522696784534302	0.06672454706489565	0	0	44.34222222222222	164.42788585185278	PRKCB
Hypoxia-inducible factor in the cardivascular system	1/16	0.024522696784534302	0.06672454706489565	0	0	44.34222222222222	164.42788585185278	EP300
Inhibition of platelet activation by aspirin	1/16	0.024522696784534302	0.06672454706489565	0	0	44.34222222222222	164.42788585185278	PRKCB
Apoptotic cleavage of cellular proteins	1/17	0.026035891626597026	0.06769331822915227	0	0	41.56875	151.65440789573447	PRKCD
Beta-arrestin-dependent recruitment of Src kinases in GPCR signaling	1/17	0.026035891626597026	0.06769331822915227	0	0	41.56875	151.65440789573447	ARRB1
Cadmium-induced DNA biosynthesis and proliferation in macrophages	1/17	0.026035891626597026	0.06769331822915227	0	0	41.56875	151.65440789573447	PRKCB
Cell to cell adhesion signaling	1/17	0.026035891626597026	0.06769331822915227	0	0	41.56875	151.65440789573447	CDH1
NO2-dependent IL-12 pathway in NK cells	1/17	0.026035891626597026	0.06769331822915227	0	0	41.56875	151.65440789573447	JAK2
Energy-dependent regulation of mTOR by LKB1-AMPK	1/17	0.026035891626597026	0.06769331822915227	0	0	41.56875	151.65440789573447	PRKAB2
Pertussis toxin-insensitive CCR5 signaling in macrophage	1/18	0.027546814940669486	0.06956066218830928	0	0	39.12156862745098	140.51952455455398	PRKCB
Activated AMPK stimulation of fatty-acid oxidation in muscle	1/18	0.027546814940669486	0.06956066218830928	0	0	39.12156862745098	140.51952455455398	PRKAB2
Downregulation of MTA-3 in ER-negative breast tumors	1/18	0.027546814940669486	0.06956066218830928	0	0	39.12156862745098	140.51952455455398	CDH1
Effect of METS on macrophage differentiation	1/18	0.027546814940669486	0.06956066218830928	0	0	39.12156862745098	140.51952455455398	HDAC5
Interferon signaling	2/168	0.02780996484928443	0.0697235547292774	0	0	8.227253842958039	29.47299227321037	PRKCD;JAK2
STAT3 pathway	1/19	0.02905547000861942	0.07182021107764378	0	0	36.946296296296296	130.736261970552	JAK2
Calcineurin in effects in keratinocyte differentiation	1/19	0.02905547000861942	0.07182021107764378	0	0	36.946296296296296	130.736261970552	PRKCB
Golgi-associated vesicle biogenesis	1/20	0.030561860107418466	0.07347406094317728	0	0	35.0	122.08008572013848	ARRB1
Apoptotic signaling in response to DNA damage	1/20	0.030561860107418466	0.07347406094317728	0	0	35.0	122.08008572013848	PRKCB
Signaling by Hippo	1/20	0.030561860107418466	0.07347406094317728	0	0	35.0	122.08008572013848	STK4
Cell differentiation pathway	1/20	0.030561860107418466	0.07347406094317728	0	0	35.0	122.08008572013848	HDAC5
ChREBP regulation by carbohydrates and cAMP	1/21	0.032065988516399045	0.07503441312837376	0	0	33.248333333333335	114.37291539918965	PRKAB2
E-cadherin keratinocyte pathway	1/21	0.032065988516399045	0.07503441312837376	0	0	33.248333333333335	114.37291539918965	CDH1
Oxidative stress-induced gene expression via Nrf2	1/21	0.032065988516399045	0.07503441312837376	0	0	33.248333333333335	114.37291539918965	PRKCB
PKC-catalyzed phosphorylation of inhibitory phosphoprotein of myosin phosphatase	1/21	0.032065988516399045	0.07503441312837376	0	0	33.248333333333335	114.37291539918965	PRKCB
TGF-beta signaling pathway	2/185	0.0331995130801827	0.07700861655413499	0	0	7.45656679856793	25.39125091150507	CDH1;EP300
CCR3 signaling in eosinophils	1/22	0.03356785849795628	0.07700861655413499	0	0	31.663492063492065	107.4717897739846	PRKCB
Nitric oxide signaling pathway	1/22	0.03356785849795628	0.07700861655413499	0	0	31.663492063492065	107.4717897739846	PRKCB
Hypoxia and p53 in the cardiovascular system	1/23	0.03506747333209365	0.07890181499721072	0	0	30.222727272727273	101.26068146954859	EP300
CREB transcription factor and its extracellular signals	1/23	0.03506747333209365	0.07890181499721072	0	0	30.222727272727273	101.26068146954859	PRKCB
Modulation of interferon signaling by chaperones	1/23	0.03506747333209365	0.07890181499721072	0	0	30.222727272727273	101.26068146954859	JAK2
Inhibition of cellular proliferation by Gleevec	1/24	0.03656483627172508	0.0812294780466804	0	0	28.907246376811596	95.64448851318153	JAK2
Lysosome vesicle biogenesis	1/24	0.03656483627172508	0.0812294780466804	0	0	28.907246376811596	95.64448851318153	ARRB1
Jak-STAT signaling pathway	2/199	0.037920776454631995	0.0816649391596368	0	0	6.921757395413968	22.649763037618957	EP300;JAK2
IGF1 receptor signaling through beta-arrestin	1/25	0.03805995059128532	0.0816649391596368	0	0	27.70138888888889	90.5445579257637	ARRB1
C-Myc pathway	1/25	0.03805995059128532	0.0816649391596368	0	0	27.70138888888889	90.5445579257637	MAX
Cellular response to hypoxia	1/25	0.03805995059128532	0.0816649391596368	0	0	27.70138888888889	90.5445579257637	EP300
PIP2 hydrolysis	1/25	0.03805995059128532	0.0816649391596368	0	0	27.70138888888889	90.5445579257637	PRKCD
Lipid and lipoprotein metabolism	3/489	0.03935966030231743	0.0816649391596368	0	0	4.295194003527337	13.89501203558189	PRKAB2;CHD9;EP300
Physiological and pathological hypertrophy  of the heart	1/26	0.03955281953600642	0.0816649391596368	0	0	26.592	85.8953057509563	PRKCB
RXR/VDR pathway	1/26	0.03955281953600642	0.0816649391596368	0	0	26.592	85.8953057509563	VDR
Interleukin-27-mediated signaling events	1/26	0.03955281953600642	0.0816649391596368	0	0	26.592	85.8953057509563	JAK2
ERBB2 role in signal transduction and oncology	1/26	0.03955281953600642	0.0816649391596368	0	0	26.592	85.8953057509563	EP300
YAP1- and WWTR1 (TAZ)-stimulated gene expression	1/26	0.03955281953600642	0.0816649391596368	0	0	26.592	85.8953057509563	CHD9
PGC-1a regulation	1/26	0.03955281953600642	0.0816649391596368	0	0	26.592	85.8953057509563	HDAC5
Cell cycle: G2/M checkpoint	1/27	0.041043446358547446	0.08327311949046332	0	0	25.567948717948717	81.6416333934617	EP300
VEGFR1 pathway	1/27	0.041043446358547446	0.08327311949046332	0	0	25.567948717948717	81.6416333934617	PRKCB
eIF4E and p70 S6 kinase regulation	1/27	0.041043446358547446	0.08327311949046332	0	0	25.567948717948717	81.6416333934617	PRKCB
Interleukin receptor SHC signaling	1/28	0.04253183431893138	0.08482201048832337	0	0	24.619753086419752	77.73693045847051	JAK2
Multi-step regulation of transcription by PITX2	1/28	0.04253183431893138	0.08482201048832337	0	0	24.619753086419752	77.73693045847051	EP300
PKB-mediated events	1/28	0.04253183431893138	0.08482201048832337	0	0	24.619753086419752	77.73693045847051	PRKAB2
Phototransduction	1/29	0.04401798665976609	0.08489183141526317	0	0	23.739285714285714	74.14151494993529	ARRB1
Adherens junction actin cytoskeletal organization	1/29	0.04401798665976609	0.08489183141526317	0	0	23.739285714285714	74.14151494993529	CDH1
IGF1 pathway	1/29	0.04401798665976609	0.08489183141526317	0	0	23.739285714285714	74.14151494993529	PRKCD
S1P/S1P3 pathway	1/29	0.04401798665976609	0.08489183141526317	0	0	23.739285714285714	74.14151494993529	JAK2
Skeletal myogenesis control by HDAC and calcium/calmodulin-dependent kinase (CaMK)	1/29	0.04401798665976609	0.08489183141526317	0	0	23.739285714285714	74.14151494993529	HDAC5
Thyroid cancer	1/29	0.04401798665976609	0.08489183141526317	0	0	23.739285714285714	74.14151494993529	CDH1
Glutamate binding and activation of AMPA receptors and synaptic plasticity	1/30	0.0455019066193127	0.08495302778392956	0	0	22.919540229885058	70.82140338003367	PRKCB
Signaling pathway from G-protein families	1/30	0.0455019066193127	0.08495302778392956	0	0	22.919540229885058	70.82140338003367	PRKCB
TRAF6-mediated IRF7 activation	1/30	0.0455019066193127	0.08495302778392956	0	0	22.919540229885058	70.82140338003367	EP300
Nectin adhesion pathway	1/30	0.0455019066193127	0.08495302778392956	0	0	22.919540229885058	70.82140338003367	CDH1
Ovarian infertility genes	1/30	0.0455019066193127	0.08495302778392956	0	0	22.919540229885058	70.82140338003367	VDR
PDGFA signaling pathway	1/30	0.0455019066193127	0.08495302778392956	0	0	22.919540229885058	70.82140338003367	PRKCB
Activated NOTCH1 signaling in the nucleus	1/31	0.04698359743176254	0.08589188905494088	0	0	22.154444444444444	67.74733246608147	ARRB1
Alpha-6 beta-4 integrin signaling pathway	1/31	0.04698359743176254	0.08589188905494088	0	0	22.154444444444444	67.74733246608147	PRKCD
Ras family activation regulation	1/31	0.04698359743176254	0.08589188905494088	0	0	22.154444444444444	67.74733246608147	PRKCB
NF-kappaB activation by non-typeable Hemophilus influenzae	1/31	0.04698359743176254	0.08589188905494088	0	0	22.154444444444444	67.74733246608147	EP300
Alpha-synuclein signaling	1/32	0.048463062337042354	0.08768316948609209	0	0	21.438709677419354	64.89397456016435	PRKCD
Syndecan 4 pathway	1/32	0.048463062337042354	0.08768316948609209	0	0	21.438709677419354	64.89397456016435	PRKCD
Syndecan 2 pathway	1/33	0.04994030455802936	0.08978497458847727	0	0	20.767708333333335	62.2393036656038	PRKCD
HIF-2-alpha transcription factor network	1/34	0.051415327328444255	0.08978497458847727	0	0	20.13737373737374	59.76407945997836	EP300
MAPK/TRK pathway	1/34	0.051415327328444255	0.08978497458847727	0	0	20.13737373737374	59.76407945997836	PRKCD
TOR signaling	1/34	0.051415327328444255	0.08978497458847727	0	0	20.13737373737374	59.76407945997836	PRKAB2
EGF receptor transactivation by GPCRs in cardiac hypertrophy	1/34	0.051415327328444255	0.08978497458847727	0	0	20.13737373737374	59.76407945997836	PRKCB
EPO receptor signaling	1/34	0.051415327328444255	0.08978497458847727	0	0	20.13737373737374	59.76407945997836	JAK2
Nuclear receptors in lipid metabolism and toxicity	1/34	0.051415327328444255	0.08978497458847727	0	0	20.13737373737374	59.76407945997836	VDR
Arf6 signal transduction regulation	1/35	0.052888133852117436	0.09144697035513902	0	0	19.544117647058822	57.45142461157597	ARRB1
Interleukin-7 signaling pathway	1/35	0.052888133852117436	0.09144697035513902	0	0	19.544117647058822	57.45142461157597	EP300
Apoptosis	2/242	0.053886006242497286	0.0921734942253959	0	0	5.669252873563218	16.559232613772952	CDH1;PRKCD
GM-CSF-mediated signaling events	1/36	0.05435872736369502	0.0921734942253959	0	0	18.984761904761903	55.2864763029152	JAK2
Phospholipids as signaling intermediaries	1/36	0.05435872736369502	0.0921734942253959	0	0	18.984761904761903	55.2864763029152	PRKCB
PI3K/PLC/TRK pathway	1/36	0.05435872736369502	0.0921734942253959	0	0	18.984761904761903	55.2864763029152	PRKCD
Interleukin-23-mediated signaling events	1/37	0.05582711106215124	0.09375749274074203	0	0	18.456481481481482	53.25609732919314	JAK2
FRA pathway	1/37	0.05582711106215124	0.09375749274074203	0	0	18.456481481481482	53.25609732919314	EP300
Signaling events mediated by HDAC class II	1/38	0.05729328816000485	0.09441288330592348	0	0	17.956756756756757	51.348635190815486	HDAC5
EGFR interaction with phospholipase C-gamma	1/38	0.05729328816000485	0.09441288330592348	0	0	17.956756756756757	51.348635190815486	PRKCD
ERBB4 signaling events	1/38	0.05729328816000485	0.09441288330592348	0	0	17.956756756756757	51.348635190815486	JAK2
Nuclear receptors	1/38	0.05729328816000485	0.09441288330592348	0	0	17.956756756756757	51.348635190815486	VDR
Angiotensin II-mediated activation of JNK pathway via Pyk2-dependent signaling	1/39	0.05875726186108227	0.09592464610809247	0	0	17.483333333333334	49.55372022159112	PRKCB
E-cadherin nascent AJ-like junctions pathway	1/39	0.05875726186108227	0.09592464610809247	0	0	17.483333333333334	49.55372022159112	CDH1
Nuclear signaling by ErbB4	1/40	0.06021903535976484	0.09785593245961786	0	0	17.034188034188034	47.86209557175929	JAK2
FOXM1 transcription factor network	1/41	0.0616786118590254	0.09930822368127484	0	0	16.6075	46.2654733568564	EP300
Fc epsilon receptor I signaling in mast cells	1/41	0.0616786118590254	0.09930822368127484	0	0	16.6075	46.2654733568564	PRKCB
FSH regulation of apoptosis	2/263	0.062413023510035616	0.09982312649431023	0	0	5.207557140969745	14.445666207339215	HDAC5;TLK1
Aldosterone-regulated sodium reabsorption	1/42	0.06313599453486288	0.09982312649431023	0	0	16.201626016260164	44.75641243015854	PRKCB
Bladder cancer	1/42	0.06313599453486288	0.09982312649431023	0	0	16.201626016260164	44.75641243015854	CDH1
VEGF, hypoxia, and angiogenesis	1/42	0.06313599453486288	0.09982312649431023	0	0	16.201626016260164	44.75641243015854	PRKCB
G-protein-mediated events	1/44	0.06604419119464339	0.10302893826364369	0	0	15.446511627906977	41.97483258957492	PRKCD
HNF3A pathway	1/44	0.06604419119464339	0.10302893826364369	0	0	15.446511627906977	41.97483258957492	EP300
ERBB2/ERBB3 signaling events	1/44	0.06604419119464339	0.10302893826364369	0	0	15.446511627906977	41.97483258957492	JAK2
Adaptive immune system	3/606	0.0664920645314261	0.10326864889615293	0	0	3.4410092395167022	9.327449698629875	CDH1;PRKCB;ZBTB16
Interleukin-12/STAT4 pathway	1/45	0.06749501152086855	0.10345305259312165	0	0	15.094696969696969	40.69079857995566	JAK2
Interleukin-3 signaling pathway	1/45	0.06749501152086855	0.10345305259312165	0	0	15.094696969696969	40.69079857995566	JAK2
Interleukin-3, interleukin-5, and GM-CSF signaling	1/45	0.06749501152086855	0.10345305259312165	0	0	15.094696969696969	40.69079857995566	JAK2
Alpha-6 beta-1 and alpha-6 beta-4 integrin signaling	1/46	0.06894365075528797	0.10521400615263513	0	0	14.75851851851852	39.471152501452366	CDH1
Immune system signaling by interferons, interleukins, prolactin, and growth hormones	2/280	0.06963229937559548	0.10580492242785287	0	0	4.884892086330935	13.015925624151148	PRKCD;JAK2
Regulation of NFAT transcription factors	1/47	0.07039011205855722	0.10603832331568062	0	0	14.43695652173913	38.311387316676615	TLE4
Delta Np63 pathway	1/47	0.07039011205855722	0.10603832331568062	0	0	14.43695652173913	38.311387316676615	VDR
ATM pathway	1/48	0.07183439859286861	0.10729308045147609	0	0	14.129078014184397	37.20739858844958	UIMC1
Post-translational regulation of adherens junction stability and disassembly	1/48	0.07183439859286861	0.10729308045147609	0	0	14.129078014184397	37.20739858844958	CDH1
FoxO family signaling	1/49	0.0732765135248936	0.10761529810559688	0	0	13.834027777777777	36.15544100556018	EP300
Arf6 integrin-mediated signaling pathway	1/49	0.0732765135248936	0.10761529810559688	0	0	13.834027777777777	36.15544100556018	CDH1
Interleukin-5 signaling pathway	1/49	0.0732765135248936	0.10761529810559688	0	0	13.834027777777777	36.15544100556018	JAK2
Ceramide signaling pathway	1/49	0.0732765135248936	0.10761529810559688	0	0	13.834027777777777	36.15544100556018	PRKCD
Type 2 diabetes mellitus	1/50	0.07471646000262763	0.10927282275384291	0	0	13.551020408163266	35.15209038871121	PRKCD
Nuclear receptor transcription pathway	1/51	0.0761542411780185	0.11091343839620121	0	0	13.279333333333334	34.194210378566844	VDR
Signaling events mediated by PTP1B	1/52	0.0775898601982381	0.11161492184254744	0	0	13.018300653594771	33.27892316228608	JAK2
Signaling events mediated by stem cell factor receptor (c-Kit)	1/52	0.0775898601982381	0.11161492184254744	0	0	13.018300653594771	33.27892316228608	JAK2
Endometrial cancer	1/52	0.0775898601982381	0.11161492184254744	0	0	13.018300653594771	33.27892316228608	CDH1
Androgen receptor regulation of biosynthesis and transcription	1/53	0.07902332022213049	0.11321300162435838	0	0	12.767307692307693	32.40358367230175	EP300
Phospholipase C-mediated cascade	1/54	0.08045462435891494	0.11479501280479326	0	0	12.525786163522012	31.56575680442027	PRKCD
T cell receptor signaling in naive CD8+ T cells	1/55	0.08188377576047076	0.11589195682227918	0	0	12.29320987654321	30.763197218330607	PRKCB
Vibrio cholerae infection	1/55	0.08188377576047076	0.11589195682227918	0	0	12.29320987654321	30.763197218330607	PRKCB
Pathogenic Escherichia coli infection	1/57	0.08473563284794243	0.11802463146677696	0	0	11.852976190476191	29.2557418815663	CDH1
Acute myeloid leukemia	1/57	0.08473563284794243	0.11802463146677696	0	0	11.852976190476191	29.2557418815663	ZBTB16
Pre-NOTCH expression and processing	1/57	0.08473563284794243	0.11802463146677696	0	0	11.852976190476191	29.2557418815663	EP300
SHP2 signaling	1/57	0.08473563284794243	0.11802463146677696	0	0	11.852976190476191	29.2557418815663	JAK2
HIV-1 Nef as negative effector of Fas and TNF	1/58	0.08615834477824497	0.11953193287416594	0	0	11.644444444444444	28.547152703267713	PRKCD
ATF2 transcription factor network	1/59	0.08757891647548653	0.12102440820037706	0	0	11.443103448275862	27.86641704377016	EP300
Androgen receptor proteolysis and transcription regulation	1/61	0.09041365153331592	0.12300461894648793	0	0	11.060555555555556	26.582496915567003	KDM3A
Leptin signaling pathway	1/61	0.09041365153331592	0.12300461894648793	0	0	11.060555555555556	26.582496915567003	JAK2
Clathrin derived vesicle budding	1/61	0.09041365153331592	0.12300461894648793	0	0	11.060555555555556	26.582496915567003	ARRB1
FGF signaling pathway	1/61	0.09041365153331592	0.12300461894648793	0	0	11.060555555555556	26.582496915567003	CDH1
Validated nuclear estrogen receptor alpha network	1/64	0.09464977990360633	0.1282705511434974	0	0	10.532275132275132	24.830594069685887	EP300
Glioma	1/65	0.09605757528589014	0.1286878203257536	0	0	10.3671875	24.288324885251964	PRKCB
Interleukin-12-mediated signaling events	1/65	0.09605757528589014	0.1286878203257536	0	0	10.3671875	24.288324885251964	JAK2
LPA receptor mediated events	1/65	0.09605757528589014	0.1286878203257536	0	0	10.3671875	24.288324885251964	PRKCD
HIF-1 transcriptional activity in hypoxia	1/66	0.09746325210209762	0.1290928358031557	0	0	10.207179487179488	23.765170565615563	EP300
Retinoblastoma protein regulation	1/66	0.09746325210209762	0.1290928358031557	0	0	10.207179487179488	23.765170565615563	EP300
Thyroid-stimulating hormone signaling pathway	1/66	0.09746325210209762	0.1290928358031557	0	0	10.207179487179488	23.765170565615563	JAK2
SIDS susceptibility pathways	1/67	0.09886681344336717	0.12948601312918612	0	0	10.052020202020202	23.26019032662989	EP300
T cell receptor signaling in naive CD4+ T cells	1/67	0.09886681344336717	0.12948601312918612	0	0	10.052020202020202	23.26019032662989	PRKCB
Telomerase regulation	1/67	0.09886681344336717	0.12948601312918612	0	0	10.052020202020202	23.26019032662989	MAX
AMPK signaling	1/68	0.1002682623878204	0.1298677494395755	0	0	9.901492537313432	22.772502698810975	PRKAB2
Activation of NF-kappaB in B cells	1/68	0.1002682623878204	0.1298677494395755	0	0	9.901492537313432	22.772502698810975	PRKCB
CD8/T cell receptor downstream pathway	1/68	0.1002682623878204	0.1298677494395755	0	0	9.901492537313432	22.772502698810975	PRKCB
NFAT involvement in hypertrophy of the heart	1/69	0.10166760200422945	0.13059840148325097	0	0	9.755392156862746	22.301280984489107	HDAC5
AP-1 transcription factor network	1/70	0.10306483535857697	0.13059840148325097	0	0	9.61352657004831	21.8457491225909	EP300
Renal cell carcinoma	1/70	0.10306483535857697	0.13059840148325097	0	0	9.61352657004831	21.8457491225909	EP300
CDC42 signaling events	1/70	0.10306483535857697	0.13059840148325097	0	0	9.61352657004831	21.8457491225909	CDH1
Long-term depression	1/70	0.10306483535857697	0.13059840148325097	0	0	9.61352657004831	21.8457491225909	PRKCB
MicroRNA regulation of DNA damage response	1/70	0.10306483535857697	0.13059840148325097	0	0	9.61352657004831	21.8457491225909	TLK1
Rac1 cell motility signaling pathway	1/71	0.10445996552065845	0.13094802820625398	0	0	9.475714285714286	21.405177919492388	CDH1
Bacterial invasion of epithelial cells	1/71	0.10445996552065845	0.13094802820625398	0	0	9.475714285714286	21.405177919492388	CDH1
Melanoma	1/71	0.10445996552065845	0.13094802820625398	0	0	9.475714285714286	21.405177919492388	CDH1
Cyclin A-Cdk2-associated events at S phase entry	1/72	0.1058529955609793	0.1322220691882695	0	0	9.341784037558686	20.978881609749415	MAX
Gastric acid secretion	1/74	0.10863276741747166	0.13473534050718217	0	0	9.084931506849315	20.166569167475306	PRKCB
E2F transcription factor network	1/74	0.10863276741747166	0.13473534050718217	0	0	9.084931506849315	20.166569167475306	EP300
Prolactin activation of MAPK signaling	1/75	0.1100195153566116	0.135974823556939	0	0	8.961711711711711	19.77937166333769	JAK2
RIG-I/MDA5-mediated induction of interferon-alpha/beta pathways	1/76	0.11140417537718053	0.13672330614472156	0	0	8.841777777777779	19.40408125999615	EP300
VEGF signaling pathway	1/76	0.11140417537718053	0.13672330614472156	0	0	8.841777777777779	19.40408125999615	PRKCB
Phosphatidylinositol signaling system	1/78	0.11416724371228316	0.1391413282743451	0	0	8.611255411255412	18.687206622741385	PRKCB
Signaling by SCF-KIT	1/78	0.11416724371228316	0.1391413282743451	0	0	8.611255411255412	18.687206622741385	JAK2
Generic transcription pathway	2/377	0.1153540699128354	0.13936950515140598	0	0	3.6034942528735634	7.782643151749773	CHD9;VDR
Signaling events mediated by hepatocyte growth factor receptor (c-Met)	1/79	0.1155456581169776	0.13936950515140598	0	0	8.500427350427351	18.344683169954745	CDH1
p73 transcription factor network	1/79	0.1155456581169776	0.13936950515140598	0	0	8.500427350427351	18.344683169954745	EP300
Opioid signaling	1/80	0.11692199671950551	0.1405466467415974	0	0	8.39240506329114	18.01218477461978	PRKCD
MAP kinase signaling pathway	1/81	0.11829626253520985	0.14171327013603638	0	0	8.287083333333333	17.689302303265983	MAX
Regular glucocorticoid receptor pathway	1/82	0.11966845858358988	0.14286948626816343	0	0	8.184362139917695	17.37564803201433	EP300
Response to elevated platelet cytosolic calcium	1/83	0.12103858786538906	0.1440154045449205	0	0	8.084146341463414	17.070854284931038	PRKCB
Small cell lung cancer	1/84	0.12240665340316831	0.14466240856738075	0	0	7.986345381526104	16.774572169983173	MAX
Cell junction organization	1/84	0.12240665340316831	0.14466240856738075	0	0	7.986345381526104	16.774572169983173	CDH1
Integrin cell surface interactions	1/85	0.123772658199863	0.1448140100938397	0	0	7.890873015873016	16.486470413825213	CDH1
C-Myb transcription factor network	1/85	0.123772658199863	0.1448140100938397	0	0	7.890873015873016	16.486470413825213	EP300
TGF-beta regulation of skeletal system development	1/85	0.123772658199863	0.1448140100938397	0	0	7.890873015873016	16.486470413825213	EP300
mRNA stability regulation by proteins that bind AU-rich elements	1/86	0.12513660526532908	0.1459234167711977	0	0	7.79764705882353	16.206234277302418	PRKCD
Androgen receptor signaling, proteolysis, and transcription regulation	1/88	0.12785833813457156	0.1486035651828961	0	0	7.617624521072797	15.668176630929226	EP300
Prostate cancer	1/89	0.1292161299361437	0.14919362370916592	0	0	7.530681818181818	15.409799629222077	EP300
Salivary secretion	1/89	0.1292161299361437	0.14919362370916592	0	0	7.530681818181818	15.409799629222077	PRKCB
Gap junction pathway	1/90	0.13057187592621022	0.1502646834429501	0	0	7.4456928838951315	15.158175594574578	PRKCB
Signaling by ERBB4	1/93	0.13462686905744525	0.1544249380364813	0	0	7.201811594202899	14.441420169325145	JAK2
ERBB signaling pathway	1/94	0.1359744617032879	0.1554626581689057	0	0	7.124014336917563	14.21446168945804	PRKCB
Developmental biology	2/420	0.13758189006119376	0.15678975133597078	0	0	3.225705329153605	6.398302565357662	CHD9;EP300
Downstream signaling events Of B cell receptor (BCR)	1/98	0.14134455256627768	0.1605564334976164	0	0	6.828865979381443	13.361050061201011	PRKCB
Senescence and autophagy	1/99	0.14268202012005496	0.16155286794238483	0	0	6.758843537414966	13.16039270810627	KMT2A
Dilated cardiomyopathy	1/100	0.14401747150131122	0.16254061896128694	0	0	6.69023569023569	12.964476920040203	PRKAB2
Pancreatic secretion	1/101	0.1453509096429046	0.16351977334826767	0	0	6.623	12.773146899499723	PRKCB
Signaling by ERBB2	1/102	0.14668233749516316	0.16449041680767498	0	0	6.557095709570957	12.586253414445132	PRKCD
Amoebiasis	1/105	0.15066458849071662	0.16841805910904947	0	0	6.36698717948718	12.05079142079369	PRKCB
ERBB1 downstream pathway	1/106	0.15198800438142535	0.16935806202501683	0	0	6.306031746031746	11.880271712830174	PRKCD
Signaling by insulin receptor	1/109	0.15594628951849215	0.17267238997157963	0	0	6.129938271604939	11.39091873922072	PRKAB2
Signaling by interleukins	1/109	0.15594628951849215	0.17267238997157963	0	0	6.129938271604939	11.39091873922072	JAK2
Signaling by EGFR in cancer	1/111	0.1585752065631873	0.17503112422540487	0	0	6.017878787878788	11.08208211129878	PRKCD
S phase	1/112	0.15988669182841242	0.1759254822312626	0	0	5.963363363363364	10.932573768600097	MAX
Leukocyte transendothelial migration	1/117	0.16641450137197006	0.18253590619237967	0	0	5.704885057471264	10.230419802957787	PRKCB
Immunoregulatory interactions between a lymphoid and a non-lymphoid cell	1/119	0.16901185764040969	0.18480735835446666	0	0	5.607627118644068	9.969163244438311	CDH1
Signaling by PDGF	1/122	0.17289321275049702	0.18846434060690823	0	0	5.467768595041322	9.596377552221062	PRKCD
Integration of energy metabolism	1/125	0.1767570211186702	0.19207961118468495	0	0	5.334677419354839	9.244885281458137	PRKAB2
Neurotrophin signaling pathway	1/126	0.1780410712140333	0.19287782714853605	0	0	5.291733333333333	9.132161270435885	PRKCD
Signaling by FGFR in disease	1/128	0.1806033594018831	0.19505162815403376	0	0	5.207874015748032	8.913026591821229	PRKCD
Cell-cell communication	1/129	0.18188160313378351	0.19582957883422702	0	0	5.166927083333333	8.806507089090594	CDH1
Cell adhesion molecules (CAMs)	1/133	0.18697530817141164	0.20008638161026063	0	0	5.009343434343434	8.399560435360442	CDH1
Membrane trafficking	1/133	0.18697530817141164	0.20008638161026063	0	0	5.009343434343434	8.399560435360442	ARRB1
Gene expression	3/968	0.18792791334822795	0.20049452153564745	0	0	2.1099925980754994	3.527267936093693	CHD9;VDR;PRKCD
Mitotic G1-G1/S phases	1/135	0.18951063804745089	0.20157040592319778	0	0	4.9340796019900495	8.2069045278778	MAX
NGF signaling via TRKA from the plasma membrane	1/136	0.19077543213279258	0.2023026485758616	0	0	4.897283950617284	8.113126058532183	PRKCD
Natural killer cell-mediated cytotoxicity	1/137	0.19203831602803864	0.2030284606200047	0	0	4.861029411764706	8.020991961652324	PRKCB
T cell receptor signaling pathway	1/139	0.1945583644683707	0.20507503281801231	0	0	4.790096618357488	7.841498751053612	PRKCB
Interleukin-5 regulation of apoptosis	1/144	0.2008252521700935	0.2110468967416252	0	0	4.621445221445222	7.418899095679858	MAX
Signaling by the B cell receptor (BCR)	1/151	0.20951967671006408	0.21952658664248506	0	0	4.404222222222222	6.8835246058197805	PRKCB
T cell receptor regulation of apoptosis	2/603	0.23978884355922161	0.25049370264668686	0	0	2.2225027253428196	3.1737262495158003	MAX;STK4
Calcium signaling pathway	1/178	0.2422058302138552	0.25226779348683437	0	0	3.727306967984934	5.28519968188763	PRKCB
Huntington's disease	1/184	0.24928973785755917	0.25887780469823457	0	0	3.604007285974499	5.006468710309246	EP300
Transmission across chemical synapses	1/190	0.25630954145270624	0.26538244557492596	0	0	3.488536155202822	4.74918643748375	PRKCB
Endocytosis	1/201	0.2690145471023502	0.27771795892036744	0	0	3.2948333333333335	4.326082633154742	ARRB1
Gastrin-CREB signaling pathway via PKC and MAPK	1/206	0.2747198708194591	0.2827761720165107	0	0	3.213658536585366	4.152057601642212	PRKCD
Signaling by NGF	1/221	0.2915784729880629	0.2992515906982751	0	0	2.992272727272727	3.687814868856789	PRKCD
Focal adhesion	1/233	0.30479170788046744	0.3119005523791372	0	0	2.8357758620689655	3.3692609053697073	PRKCB
Antigen presentation: folding, assembly, and peptide loading of class I MHC proteins	1/255	0.3283991729634097	0.33508171427371164	0	0	2.5872703412073492	2.8809912928001724	ZBTB16
Interleukin-4 regulation of apoptosis	1/267	0.3409470297572932	0.34687654331828954	0	0	2.469047619047619	2.6567647460323824	VDR
Neuronal system	1/283	0.3573250629126951	0.3624887198912023	0	0	2.3270685579196217	2.3948080601966284	PRKCB
Oncostatin M	1/311	0.385043615555974	0.3894821586747748	0	0	2.1138709677419354	2.0174756273808483	STK4
Innate immune system	1/319	0.39274832094126255	0.3961340823286872	0	0	2.059853249475891	1.9251105795717496	EP300
Signaling by GPCR	2/977	0.45137187071066603	0.4539585289955409	0	0	1.3435190097259062	1.0687206457599794	PRKCB;PRKCD
Disease	1/674	0.6547609444471321	0.6566316900026953	0	0	0.9557206537890045	0.40473343778981524	PRKCD
Metabolism	2/1615	0.7264822323487957	0.7264822323487957	0	0	0.7848301515702162	0.2507856098493662	CHD9;EP300
